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TRPM7 is an unusual bi-functional protein containing an ion channel covalently linked to a protein kinase
domain. TRPM7 is implicated in regulating cellular and systemic magnesium homeostasis. While the
biophysical properties of TRPM7 ion channel and its function are relatively well characterized, the function of
the TRPM7 enzymatically active kinase domain is not understood yet. To investigate the physiological role of
TRPM7 kinase activity, we constructed mice carrying an inactive TRPM7 kinase. We found that these mice
were resistant to dietary magnesium deprivation, surviving three times longer than wild type mice; also they
displayed decreased chemically induced allergic reaction. Interestingly, mutant mice have lower magnesium
bone content compared to wild type mice when fed regular diet; unlike wild type mice, mutant mice placed on
magnesium-depleted diet did not alter their bone magnesium content. Furthermore, mouse embryonic
fibroblasts isolated from TRPM7 kinase-dead animals exhibited increased resistance to magnesium
deprivation and oxidative stress. Finally, electrophysiological data revealed that the activity of the kinase-dead
TRPM7 channel was not significantly altered. Together, our results suggest that TRPM7 kinase is a sensor of
magnesium status and provides coordination of cellular and systemic responses to magnesium deprivation.
T
RPM7 is an ubiquitously expressed protein that has an unusual structure: it contains both an ion channel
and a protein kinase within a single polypeptide chain. TRPM7 is an essential gene and its knockout results
in arrest of cell proliferation1,2 and early embryonic lethality in mice2,3. TRPM7 and its close homolog,
TRPM6, are the only known channel kinases in vertebrates, and both have been implicated in regulation of Mg21
homeostasis (reviewed in ref. 4). TRPM7 and TRPM6 are known to form TRPM6/7 heterooligomers that could
mediate relatively high magnesium currents in intestinal and kidney epithelia cells involved in mediation of
magnesium uptake5,6. Several works showed that TRPM6 can form magnesium-permeable channels on its own7,8,
however other studies suggested that TRPM6 can function only as a TRPM6/7 heterooligomer6.
TRPM7 ion channel domain belongs to a family of Transient Receptor Potential Melastatin-related (TRPM)
channels (reviewed in refs. 9–13). The biophysical properties of TRPM7 are relatively well characterized4. A
number of works have established TRPM7 as a divalent cation specific channel that is permeable to a number of
physiologically important divalent cations, including Mg21 and Ca21, as well as to some toxic divalent cations.
The TRPM7 channel is constitutively active and is regulated by free intracellular Mg21 and Mg-ATP1,14,15. The
biophysical properties of heterologously expressed TRPM7 are quite well understood; less is known about native
TRPM7 (reviewed in ref. 4). Endogenous TRPM7-like currents have been detected in all cell types examined thus
far5,6,16. A recent study found that endogenous TRPM7 currents assessed in human embryonic kidney cells (HEK-
293) had an IC50 for intracellular Mg21 comparable to heterologous systems17.
Mg21 is an abundant intracellular cation that plays indispensible structural and functional roles in many
cellular activities. The TRPM7 channel was suggested to provide a major mechanism of Mg21 entry into the cell,
thus regulating both cellular18 and whole body Mg21 homeostasis2. Deletion of Trpm7 results in severe prolif-
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require Mg21. Indeed, raising Mg21 concentration in the growth
medium fully rescues proliferation defects of Trpm7 mutant cells2,19,
suggesting that the major role of TRPM7 is regulating Mg21 intake.
Consistent with the key role of TRPM7 in proliferation of most cell
types, homozygous deletion of Trpm7 in mice causes early embry-
onic lethality2,3. In our previous work we showed that TRPM7 kinase
domain-deficient (Dkinase) embryonic stem cells do not proliferate
in regular medium containing 1 mM Mg21, and their proliferation
defect can be rescued by adding 10 mM Mg21 to the medium2. These
findings were recently confirmed in a study from another labor-
atory20. Significantly, Trpm7Dkinase/1 heterozygous mice are viable
and develop Mg21 deficiency that can be rescued by additional diet-
ary Mg21 2.
The function of TRPM7 kinase is not well understood. The kinase
domain of TRPM7 belongs to an atypical alpha-kinase family21. Alpha
kinases do not display sequence similarity to conventional protein
kinases and are able to phosphorylate residues within alpha –helices,
while conventional kinases phosphorylate residues within unstructured
and flexible regions22,23. The TRPM7 protein kinase domain is enzy-
matically active and has been shown to phosphorylate a number of
substrates in vitro, including Annexin I and Myosin II24–27. However,
the in vivo significance of these observations is not yet clear.
Since there is a good number of examples when the activity of a
channel is regulated by phosphorylation28, the presence of a channel
and a kinase within a single polypeptide chain of TRPM7 may sug-
gest that the kinase activity influences the channel function. Indeed,
some studies have suggested that the TRPM7 kinase could affect the
channel, modulating its sensitivity to Mg21 inhibition; however,
other studies reported that TRPM7 kinase activity did not alter chan-
nel function, making the effect of kinase activity on the TRPM7
channel controversial (reviewed in ref. 4).
Initially it was suggested that TRPM7 kinase is required for chan-
nel activity; it was shown that in the absence of ATP the channel was
inactive and could be activated by addition of ATP29. However, it was
pointed out that in this work Na-ATP salt was used and therefore the
stimulatory effect of ATP addition is most likely due to chelation of
Mg21 by ATP, resulting in the relieving of the channel inhibition by
Mg21 30. Indeed later it was shown that TRPM7 lacking kinase activ-
ity has the same channel activity as the wild type TRPM7 channel in
the absence of Mg21 18. Interestingly, this study also demonstrated a
slightly decreased sensitivity of these channels to magnesium inhibi-
tion18. Subsequently, more detailed studies confirmed these observa-
tions suggesting that the kinase domain is involved in mediating the
inhibition of TRPM7 channel activity by magnesium, serving as a
binding site for Mg21 and Mg-ATP31. Matsushita and colleagues
showed that the phosphotransferase activity of the kinase domain
was not required for channel function since cells expressing kinase-
inactive TRPM7 displayed active TRPM7 channel currents similar to
the ones in control cells. However, they also reported that abrogation
of the kinase activity did not affect the channel sensitivity to the
inhibition by Mg21 32. It should be noted that all these experiments
were performed on cell lines overexpressing recombinant TRPM7.
To address the physiological role of TRPM7 kinase and to study it
in vivo we constructed a knock-in mouse strain in which the kinase
activity is abrogated by changing Lys-1646 to Arg in the ATP-bind-
ing site of TRPM7 kinase domain. Our results demonstrate that
although TRPM7 kinase-dead mice have essentially normal pheno-
type and unaltered TRPM7 channel activity, they exhibit resistance
to dietary Mg deprivation. Our findings suggest that TRPM7 kinase
takes part in a signaling mechanism sensing magnesium status of the
organism and as such TRPM7 kinase may play a role of a sensor for
cellular and systemic Mg21 status.
Results
Constructing the mouse strain with inactive TRPM7 kinase. To study
the physiological role of TRPM7 kinase phosphotransferase activity we
used a genetic approach: we generated a TRPM7 kinase-dead allele in
which lysine 1646 was replaced with an arginine. Lysine 1646 is essential
for Mg-ATP binding; its replacement with arginine was shown to result
in a complete loss of a TRPM7 kinase activity32. The knock-in mice were
produced using a gene-targeting vector technique, with further mouse
colony generation. The targeting vector was constructed and integrated
using an in vivo recombination strategy (Fig. 1). The resulting chimeric
mice demonstrated germline transmission of the kinase-dead TRPM7
allele.
TRPM7K1646R/K1646R mice have an essentially normal phenotype.
Neither TRPM7K1646R/K1646R nor TRPM7K1646R/1 mice displayed any
notable anatomical or physiological abnormalities. The mutant
mice grew and gained weight normally during the first 9 months
of their life (Fig. 2). However by 19 month of age TRPM7K1646R/K1646R
mice exhibited slightly reduced weight compared to wild type
controls (Fig. 2). Litter sizes were similar for mutant and wild type
mice, ranging from 7 to 8 pups per litter. The pups developed
normally at a normal growth rate, maturing at the age of 3–4
weeks. The mean life span for both mutant and wild type mice
was 32 months when maintained on a regular diet. Finally, we did
not observe any obvious behavioral differences between mutant and
wild type animals.
TRPM7K1646R/K1646R mice exhibited resistance to dietary Mg21
deprivation. Since TRPM7 is implicated in the regulation of Mg21
homeostasis, we hypothesized that the phenotype of the TRPM7
kinase-dead allele may be revealed specifically under conditions of
Mg21 deprivation. Thus, we placed the TRPM7K1646R/K1646R mutant
and control wild type mice on Mg21-depleted diet, which
contained 0.003% of Mg21. The onset of mortality for the wild type
animals occurred at about 20 days of being placed on Mg21-depleted
diet. In contrast, the homozygous mutant mice started to die after
about 60 days (Fig. 3). The median life span of homozygous mutant
mice on a Mg21-depleted diet increased approximately three-fold –
from 2 months to 6 months compared to wild type mice. The
maximal life span also increased. The life span of heterozygous
mutants also increased compared to wild type mice though to a
smaller extent than in homozygous mutants (Fig. 3).
TRPM7K1646R/K1646R MEFs are resistant to Mg21 deprivation. Next,
we analyzed the ability of cells derived from the null mutant animals
to adapt to low concentrations of Mg21. We isolated mouse
embryonic fibroblasts (MEFs) from wild type and homozygous
mutant animals and compared their growth dynamics in regular
(1 mM Mg21) and Mg21-depleted media. The two types of MEFs
grew equally well in regular medium. However, when plated in
Mg21-depleted medium, the wild type MEFs exhibited transient
growth arrest, while the growth of mutant MEFs was unchanged
relative to their growth in 1 mM Mg21 (Fig. 4). Thus, MEF’s
derived from kinase-dead mice were resistant to growth arrest
caused by Mg21 depletion. The Mg21-depleted medium was
prepared using a custom made Mg21-free DMEM and dialyzed
serum replacement. The residual Mg21 concentration (i.e. Mg21
that cannot be completely removed because it is tightly bound to
serum proteins) was determined by atomic absorption spectrometry
to be in the 10–20 mM range.
Since TRPM7 can form heteroologomers with TRPM65,6 and
TRPM7 kinase can trans-phosphorylate TRPM633, it is possible that
TRPM6 may play a role in aforementioned observed effects of mag-
nesium deprivation in MEFs. We performed RT (reverse transcrip-
tase)-PCR and found that there was no expression of TRPM6 in both
wild-type and TRPM7 kinase-dead mutant MEFs (see Supplementary
materials Figure 1). Therefore, the observed effects of K1646R
mutation on Mg21 sensitivity in MEFs cannot be mediated by
TRPM6.
www.nature.com/scientificreports
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Figure 1 | Generation of TRPM7K1646R/K1646R knock-in mice. (A) Schematic representation of the endogenous Trpm7 locus and the targeting vector;
homologous recombination strategy was used to engineer embryonic stem (ES) cells; the vector contained K1646R (KR) point mutation in exon 34 that
replaced lysine residue at position 1646 to arginine. (B) DNA isolated from mouse tail biopsies of F1 heterozygous offspring was analyzed by PCR to
confirm the presence of an introduced Neo-cassette; primer set A2/F3 amplified a fragment of 2.6 kb when the Neo-cassette was introduced by the
targeting construct. 1 kb ladder was used as a reference (lane 1); lanes 2, 5 and 6 represent PCR products amplified from representative DNA samples of F1
offspring of mice that did not contain NEO-cassette; lanes 3 and 4 represent PCR products amplified from representative tail DNA samples of F1 offspring
of mice that were targeted correctly and contained NEO-cassette. (C) Confirmation of point mutation: tail DNA sample from correctly targeted F1
representative mouse was amplified using primer set SQ1/UNI (lane 1); generated product of 1.75 kb size was used for further sequencing analysis to
confirm the introduced point mutation. 1 kb ladder was used as a reference (lane 2); the expanded correctly targeted ES clone was used as a positive
control (lane 3) and wild type ES clone was used as a negative control (lane 4). (D) Tail DNA samples of representative F2 offspring mice were analyzed to
confirm the point mutation presence and Neo-cassette deletion: to genotype wild type (1/1), TRPM7K1646R/1 (KR/1) and TRPM7K1646R/K1646R (KR/KR)
mice F4/R4 primer set was used to generate 640 b.p. product for knock-in allele and 440 b.p. product for wild type allele. Lanes 1 and 2 show PCR
products amplified from tail DNA samples of representative TRPM7K1646R/K1646R mice; lanes 3 and 4 show PCR products amplified from tail DNA samples
of representative wild type mice; lanes 5 and 6 show PCR products amplified from tail DNA samples of representative TRPM7K1646R/1 mice; 1 kb ladder
was used as a reference (lane 7). (E) The PCR products from SQ1/UNI reaction shown in C (lane 1) were sequenced with SQ2 primer to demonstrate the
presence of the K1646R mutation: T R C replacement and representative traces are shown for representative F1 offspring mouse.
www.nature.com/scientificreports
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Delayed-type of hypersensitivity response to oxazolone (allergic
reaction). It is known that low magnesium status conditions
correlate with cell-extrinsic enhancement of systemic inflammatory
and allergic responses34. Since TRPM7 kinase-dead mice displayed
Mg21 deprivation resistance we decided to evaluate their allergic
reaction under magnesium deprivation conditions. Therefore, we
evaluated the allergic reactions of TRPM7 kinase-dead animals by
performing oxazolone sensitization experiments to evaluate the level
of delayed-type hypersensitivity responses in mice.
One week prior to sensitization, wild type and TRPM7 kinase-dead
mice were adapted to the control (0.2% Mg21) diet. Under these con-
ditions, TRPM7 kinase-dead mice displayed an oxazolone treatment
sensitivity response similar to wild-type animals (Fig. 5). When the
mice were placed on Mg21-deficient diet, the wild type animals dis-
played an elevated allergic reaction to oxazolone treatment, while the
response of the mutant mice to the treatment did not change (Fig. 5).
When the mice were placed on a Mg21-supplemented diet (0.3%), the
hypersensitivity to oxazolone was fully abrogated in wild type mice,
whereas TRPM7 kinase-dead mice were, again, unaffected. Therefore,
Mg21 -deficient diet does not enhance allergic response in TRPM7
kinase-dead mice. These results are consistent with increased survival
of TRPM7 kinase-dead mice under the conditions of dietary Mg21
deprivation. Taken together, our results demonstrate Mg21 deprivation
resistant phenotype of TRPM7 kinase-dead mice.
TRPM7K1646R/K1646R MEFs are oxidative stress resistant. Mg21
deprivation is known to cause inflammation and elevate the levels
Figure 2 | The body weight of wild type and TRPM7K1646R/K1646R mice at different ages. Open and shaded bars correspond to wild type and TRPM7
kinase-dead mice respectively. Values are means 1/2 the standard error of the mean. A Student’s t-test was used to calculate p-values (n 5 7–13 mice per
group); P , 0.05 was considered significant. * Significantly different from wild type mice of the same age. The difference for the body weight of wild type
and kinase-dead mice at 19 month of age was significant with P-value 0.005.
Figure 3 | K1646R mutation in TRPM7 confers resistance to Mg21
deprivation in mice. Animals carrying the TRPM7 kinase-dead allele
showed improved survival on a Mg21-deficient diet. The number of
animals in was 20–22 per group of mice; each group contained equal
numbers of males and females. The survival curves were significantly
different with a log-rank (Mantel-Cox) test p-value , 0.02. The trends for
the survival curves were also significantly different with a log-rank p-value
of 0.005.
Figure 4 | TRPM7K1646R/K1646R MEFs are resistant to Mg21 deprivation.
Unlike WT cells, homozygous mutant MEFs proliferate equally well in the
absence and presence of 1 mM Mg21 in the growth medium. The results of
experiment represent the average means of 3 experiments 12 s.e.m.
www.nature.com/scientificreports
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of reactive oxygen species (reviewed in ref. 35), with the inflammatory
response proposed to be responsible for oxidative damage during Mg21
deficiency36. Since the kinase-dead mice displayed a significantly lower
delayed-type response and sensitivity to oxazolone during Mg21
deprivation compared to wild type animals, we explored the effect of
loss of TRPM7 kinase activity on sensitivity to oxidative stress. To this
end, MEFs isolated from wild type and TRPM7 kinase-dead mice were
treated with hydrogen peroxide. After 1 hour of incubation the number
of adhering wild type MEFs significantly decreased while the number of
adhering TRPM7 kinase-dead MEFs did not change, suggesting that the
TRPM7 kinase-dead cells were indeed more resistant to oxidative stress
(Fig. 6).
Evaluation of Mg21 status. The resistance of TRPM7 kinase-dead
mice to dietary depletion of Mg21 can arise either from undisturbed
Mg21 status or from an inability to sense an alteration in Mg21 status.
To assess Mg21 status we analyzed Mg21 concentration in blood
serum of wild type and TRPM7 kinase-dead mice fed either
standard or Mg21-depleted diet. We found that Mg21
concentration in the blood serum of wild type and TRPM7 kinase-
dead animals was reduced to a similar extent by Mg21 deprivation
(Fig. 7A).
The main physiological way to access Mg21 during hypomagne-
saemia is to utilize Mg21 in bones, which represent the body’s largest
Mg21 storage. Thus, we measured Mg21 concentration in the bones
of wild type and TRPM7 kinase-dead animals. We found that the
wild type mice responded to Mg21 deprivation as expected, i.e. by
utilizing bone Mg21 and thus lowering the Mg21 concentration in
their bones (Fig. 7B). Interestingly, in TRPM7 kinase-dead mice,
under normal conditions bone Mg21 concentration was decreased
relative to controls and was insensitive to Mg21 deprivation, remain-
ing unchanged upon switch to a low Mg21 diet (Fig. 7B). These
results indicate that a deficit in dietary Mg21 was not compensated
by accessing bone Mg21 in Mg21 deprived TRPM7 kinase-dead mice,
suggesting that TRPM7 kinase is necessary for sensing the lowered
Mg21 status.
Wild type and K1646R mutant TRPM7 channels have similar
Mg21 sensitivity in the physiological range. Electrophysiological
analysis in heterologous overexpression systems has shown that
the point mutation K1648R in human TRPM7 protein renders
channel activity less sensitive to intracellular Mg21 inhibition at
Figure 5 | The effect of TRPM7 kinase deficiency and Mg21 content in the
diet on the oxazolone sensitivity reaction in mice. The delayed sensitivity
response is measured as a change in the ear thickness, mm. Before ear
application of oxazolone wild type and TRPM7 kinase-dead mice were fed
for 7 days a severely Mg21 deficient, control and supplemental Mg21 diet
with 0.003, 0.1, and 0.3% Mg21, respectively. The swelling response was
measured 24 h after the challenge. Calculations of the swelling response
were carried out comparing with the respective control groups not exposed
to oxazolone. All mice were 4 months of age. Open and shaded bars
correspond to wild type and TRPM7 kinase-dead mice respectively. Values
are means 12 s.e.m. Two-way of analysis of variant test was used for the
calculations (n 5 7–13-mice per group); P , 0.05 was considered
significant; * significantly different from wild type mice fed a respective
0.003% Mg diet with P value , 0.01.
Figure 6 | TRPM7K1646R/K1646R MEFs are oxidative stress-resistant. MEFs from kinase-dead mutant and wild type mice were grown in normal conditions
and subsequently treated with 400 uM of hydrogen peroxide for 1 hour. Pictures were taken before and after 1 hour of hydrogen peroxide treatment. The
density of the wild type MEFs after treatment is reduced compared to the KR mutant MEF cells.
www.nature.com/scientificreports
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low intracellular Mg21 concentrations18. We therefore completed
two full dose-response curves of TRPM7 to intracellular free Mg21
in MEFs isolated from both wild type (WT) and TRPM7 K1646R
mutant (KR) mice (Fig. 8A, B). WT currents had an IC50 of 71 6
22 mM with a Hill coefficient of 0.7, where as TRPM7 KR mutants
had an IC50 of 378 6 127 mM with a Hill coefficient of 1.6 (fits not
shown). Current amplitudes plateaued at 70 mM intracellular Mg21
in the TPRM7 KR mutant, whereas WT had not reached plateau with
Mg21 concentrations as low as 25 mM, and needed the complete
removal of intracellular Mg21 to reach the plateau phase (Fig. 8C).
Normalized current amplitudes between the two mouse models at
nominally free (0 mM) intracellular Mg21 were statistically different
with p , 0.05 as assessed by Student’s T-test. A sigmoidal curve fit to
the current development of individual cells from datasets in Fig. 8A
and 8B was performed to assess the average maximal current
amplitude, half-time to maximal current, and rate of current
development (see methods) at 0 mM, 70 mM and 210 mM
intracellular free Mg21 concentrations. This revealed that TRPM7
K1646R currents reached half-maximal current 70 s earlier than WT
at 0 mM Mg21 (182 s 6 36 s compared to WT with 252 s 6 21 s, n 5
5 each), however there was no difference in the rate of current
development (58 s 6 8 s compared to WT with 56 s 6 8 s). At
70 mM Mg21, TRPM7 K1646R currents also reached half-maximal
currents earlier than WT (150 s 6 20 s vs. 360 s 6 37 s, respectively;
n 5 5 each), and in addition showed faster rate of current
development (43 s 6 5 s compared to WT with 97 s 6 21 s). At
and above 210 mM intracellular free Mg21 however, WT TRPM7
currents reached the half-maximal current point faster than the
K1646R mutant currents (310 s 6 41 s vs. 537 s 6 185 s,
respectively) and had a faster rate of current development (98 s 6
23 s vs. 233 s 6 76 s, respectively). None of the observed differences
were statistically significant.
To assess whether the amount of active channel proteins was
similar in both mouse models, we kept the intracellular solution
Mg21 free and in addition applied a divalent-free extracellular solu-
tion to the fully developed TRPM7 current (see methods). This con-
firmed that there was no significant difference in the amount of
TRPM7 channels in the plasma membrane between WT and
TRPM7 K1646R mutant MEFs (Fig. 8E, F). We conclude that WT
and TRPM7 K1646R mutant channels in MEFs have similar intra-
cellular Mg21 sensitivity, particularly at physiological Mg21 levels.
Discussion
Our results demonstrate that inactivation of TRPM7 kinase affects
the ability of the cells and the whole organism to sense and respond to
Mg21 deprivation. The mice lacking TRPM7 kinase activity survive
severe dietary Mg21 deprivation significantly better then the wild
type mice.
It is known that Mg21 deficiency status correlates with enhanced
systemic inflammation and allergic responses34. In line with better
Mg21 deprivation survival of TRPM7 kinase-dead mice, they did not
display elevated delayed -type hypersensitivity (allergic) response
under severe dietary Mg21 deprivation conditions. Similarly, on
the cellular level TRPM7 kinase deficiency rendered MEFs resistant
to Mg21 deprivation: the growth rate of MEFs obtained from TRPM7
kinase-dead mice was not suppressed by Mg21 depletion in the media
while MEFs from the wild type mice displayed transient growth
arrest.
Our results may have the following possible explanations: either
loss of TRPM7 kinase activity improves the ability of cells and the
whole organism to maintain the normal range of Mg21 or it affects
the ability to sense and respond to lowered Mg21 concentrations. It is
possible that kinase-dead mice can maintain Mg21 homeostasis bet-
ter than wild type animals under the conditions of Mg21 deprivation.
One of the important markers of Mg21 deficiency in mammals is
lowered Mg21 in bones, which serve as a major Mg21 storage in the
body. Severe Mg21-depleted diet caused a significant loss of Mg21
from the bones of wild type mice and brought their Mg21 bone
concentrations to the similarly lower level as the ones we observed
for TRPM7 kinase-dead mice. Also Mg21 concentrations in the blood
plasma under conditions of severe dietary Mg21 deprivation were
lowered to the same extent in both types of mice. Interestingly,
TRPM7 kinase-dead mice have lowered Mg21 concentrations in
the bones while being on a regular diet. Therefore the better ability
of TRPM7 kinase-dead mice to maintain Mg21 homeostasis is
unlikely. It is more plausible that abrogation of TRPM7 kinase activ-
Figure 7 | Assessment of Mg21 status in TRPM7K1646R/K1646R mice. The mice that were fed a control (0.2% Mg21) diet and Mg21-depleted (0.003% Mg21)
diet for 14 days prior to blood serum and bone sample preparation. (A) Mg21 concentration in the blood serum of TRPM7 kinase-dead mutant
and wild type mice was similarly reduced upon Mg21 deprivation. (B) Mg21 concentration in bones of the TRPM7 kinase-dead was reduced relative to
wild type mice under conditions of regular Mg21 but not sensitive to Mg21 deprivation. Shaded and open bars correspond to wild type and TRPM7
kinase-dead mice respectively. Values are means 12 s.e.m. Two-way of analysis of variance test was used for the calculations (n 5 5–7 -mice per group);
P , 0.05 was considered significant; * significantly different from wild type mice fed a respective 0.003% Mg diet with P value , 0.01. All mice were males
6 month of age.
www.nature.com/scientificreports
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ity leads to a loss of the ability of the cells and the whole organism to
sense lowered Mg21 status and to properly respond to it.
Since TRPM7 is a bi-functional protein and is implicated in cel-
lular and systemic Mg21 homeostasis (reviewed in ref. 4) it is possible
that some effects of TRPM7 abrogated kinase activity may be due to
TRPM7 altered channel function. While it is generally accepted that
the kinase activity is not required for the channel gating, there is a
number of studies that suggest that the kinase can modulate the
activity of the channel. The question whether TRPM7 kinase can
affect TRPM7 channel activity is controversial. In the systems using
HEK cells overexpressing human TRPM7 it was demonstrated that
the K1646R mutation leads to a decrease in channel sensitivity to
Mg21 inhibition18. However, in another study with the TRPM7
K1646R mutant overexpressed in HEK cells this effect was not
observed32. Schmitz and colleagues18 found that both wild type and
kinase-dead TRPM7 currents had similar amplitudes at 0 mM Mg21
and they both were inhibited by 5 mM Mg21. However, they found
that at 3 mM Mg21 TRPM7 kinase-dead mutant current was signifi-
cantly higher than the wild type TRPM7 current. Matshushita and
colleagues obtained similar results concerning the nonessential role
of TRPM7 kinase activity for TRPM7 channel activation and mutant
TRPM7 channel currents Mg21 inhibition effects32. However, they
did not find any significant difference in sensitivity to Mg21 inhibi-
tion between wild type and K1646R mutant TRPM7 channel
Figure 8 | Mg21 dose-response curve and divalent-free solution application on wild type (WT) and K1646R (KR) mutant TRPM7 currents in MEFs. (A)
Development of endogenous TRPM7 currents in wild type (WT) MEFs in response to increasing intracellular free Mg21 concentrations ranging between
0 mM and 3200 mM as indicated by the symbols (n 5 5–7). Currents were elicited by a voltage ramp ranging from 2100 mV to 1100 mV over
50 ms and given at 0.5 hz. Currents were extracted at 180 mV, normalized for cell size as pA/pF, averaged, and plotted against time. Error bars are S.E.M.
(B) Same conditions as in panel A, but assessed in TRPM7 KR mutant MEFs (n 5 5–7). (C) Bar graph of averaged and normalized TRPM7 currents in WT
and KR mutant MEFs. Data are taken from panels A and B displaying averaged current amplitude at 600 s experimental time and 180 mV. The star
indicates statistical significance with p , 0.05. (D) Averaged endogenous TRPM7 current-voltage (I/V) relationship in WT and KR mutant MEFs in the
absence of intracellular Mg21 and extracted at 500 s (WT) or 400 s (KR) into the experiment (n 5 5 each). Arrow indicates the voltage (180 mV) where
current amplitudes displayed in panel A and B were extracted. (E) Development of averaged and normalized endogenous TRPM7 currents in WT and KR
mutant MEFs in absence of intracellular Mg21 extracted at 180 mV over time. Voltage protocol and analysis as in panel A. Application of divalent-free
external solution (see methods) at 400 s into the experiment, as indicated by the black bar (n 5 7–9). Note the addition of 1 mM CsEDTA to the
intracellular solution (see methods) to further reduce nominally free Mg21 concentrations. (F) Average I/V relationship of endogenous WT (solid line)
and KR mutant (dotted) TRPM7 currents extracted at experimental time 398 s (before application) and 450 s (at the end of application) (n 5 7–9).
Arrow indicates the voltage (180 mV) where current amplitudes displayed in panel E were extracted.
www.nature.com/scientificreports
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currents. The reason for the discrepancy is unknown; it may be
related to differences in experimental procedures since Matsushita
et al. used transient cell transfection while Schmitz et al. employed
stable transfection for their experiments.
Another mechanism may be relied on ability of TRPM7 to modu-
late functions of other magnesium transporters. Among ,20 putat-
ive magnesium transporters/channels, TRPM6 is the most likely
candidate for such modulatory mechanism. It was shown previously
that TRPM6 and TRPM7 can form heteromeric channel complexes
to regulate magnesium uptake by epithelial cells in the kidney and
intestine (reviewed in refs. 11, 13). Furthermore, heterologous
expression studies revealed that TRPM7 kinase can trans-phosphor-
ylate TRPM633. Thus, it is possible that TRPM6/7 channel-kinase
complexes lacking TRPM7 kinase activity do not respond properly
to magnesium deprivation in TRPM7 kinase-dead mice. However,
the effect of TRPM7 kinase inactivation on magnesium sensitivity in
MEFs cannot be explained by TRPM6, since we found that TRPM6 is
not expressed in MEFs (see Supplementary material, Figure 2).
In our experiments we found that endogenous currents in primary
WT and TRPM7 kinase-dead MEFs are similarly sensitive to intra-
cellular Mg21. A difference in maximal current amplitude between
WT MEFs and kinase-dead MEFs was observed for 0 mM intracel-
lular Mg21, but no difference was observed for all other Mg21 con-
centrations, including the physiological range. Quantification of the
time required to reach half-maximal current amplitudes and rates of
current development showed increased kinetics for the TRPM7 KR
mutant compared to TRPM7 WT at Mg21 concentrations below
210 mM, however this was not statistically significant. Thus, absence
of kinase phosphotransferase activity does not significantly alter
TRPM7 channel behavior in MEFs in regards to intracellular Mg21.
Disruption of phosphotransferase activity also does not seem to
change the available number of TRPM7 channels in the plasma
membrane, as evidenced by our DVF experiment (Fig. 8E, F). The
slight difference in current behavior seen between Fig. 8A, B com-
pared to 8E at 0 mM free Mg21 could be due to the addition of EDTA
to the intracellular solution for the DVF experiments (Fig. 8E).
Chelating not only Ca21 but also other divalent ion contaminants
by EDTA might affect channel conformation and activity.
Furthermore, in contrast to other cell types studied1,2, removal of
divalent ions linearizes TRPM7 currents in MEFs, but does not sig-
nificantly increase overall current amplitudes at depolarized
potentials.
A recent study found that endogenous TRPM7 currents assessed
in HEK-293 cells had an IC50 for intracellular Mg21 comparable to
heterologous systems, as did endogenous TRPM7 in SHEP (570 mM,
720 mM, 425 mM, respectively17). It is interesting to observe that
native TRPM7 channels in primary MEFs seem more sensitive to
intracellular Mg21 than in the cell line HEK293 or SHEP-21N cell
lines, which could point to different regulatory proteins determining
overall channel activity in these diverse cell systems. Even in experi-
mental hypomagnesemic condition intracellular Mg21 is not
expected to fall to less than a few hundred mM37,38, therefore it can
reasonably be expected that TRPM7 activity is kept suppressed in
MEF under normal circumstances, regardless of phosphotransferase
activity. If TRPM7 channel Mg21 dependence is similar in other cell
types to the one observed in MEFs, it can be concluded that TRPM7
channel activity is unlikely to be significantly affected by its kinase
activity and the effects observed in TRPM7 kinase-dead mice and
MEFs obtained from them are not due to an altered channel function.
Very recently Kaitsuka et al. reported the generation of TRPM7
kinase-dead mice by introducing a K1646R point mutation39. They
analyzed some aspects of phenotype of kinase-inactive mutant mice
as well as electrophysiological properties of TRPM7 channels in cells
derived form these mice39. In their experiments kinase-dead mice
had normal blood serum total magnesium and calcium levels. The
viability was normal, as well as food intake, body weight and loco-
motor activity. Our results are in general agreement with the results
of Kaitsuka et al. In our experiments we also did not observe any
differences in blood serum magnesium and viability. Although we
observed no body weight differences up to the age of 9 months, 30%
reduced body weight was observed for 19-month-old kinase-dead
mutant mice. That difference was not observed by Kaitsuka et al,
since they monitored the body weight for the first 10 months of
animal’s life. We also found significant differences in phenotypes
of MEFs obtained from mutant and wild type animals under the
conditions of magnesium deprivation. Electrophysiological studies
in Kaitsuka et al. paper revealed that inactivation of TRPM7 kinase
does not significantly affect the function of endogenous TRPM7
channels. The experiments were performed on peritoneal macro-
phages derived from TRPM7 kinase-dead mice. In our studies we
performed electrophysiological experiments on MEFs and our
results are in general agreement with that of Kaitsuka et al.
Our results demonstrate that in MEFs the abrogation of TRPM7
kinase activity does not significantly alter channel activity. It is pos-
sible that the previously observed effects of TRPM7 kinase inactiva-
tion on TRPM7 channel Mg21 sensitivity were due to an indirect
effect of additional cellular components that are absent in MEFs.
Although TRPM7 kinase can autophosphorylate at multiple sites40
our results suggest that such phosphorylation is unlikely to be
involved in the regulation of the channel activity. Our results also
indicate that TRPM7 kinase is necessary for sensing the lowered
Mg21 concentrations since absence of the kinase activity leads to cell
and organism insensitivity to lowered Mg21 status, which in turn
results in better survival of the organism under the conditions of
Mg21 deprivation.
Furthermore, since the kinase-dead mutant animals could survive
significantly longer under conditions of Mg21 deficiency than wild
type animals, it can be suggested that death caused by Mg21 depriva-
tion is not due to insufficient amount of Mg21 per se (e.g. as required
for some vital processes) but rather due to some toxic signaling path-
ways that are activated by Mg21 deficiency via activity of TRPM7
kinase. Thus, our data suggest that physiological function of TRPM7
kinase is related to Mg21 status and is part of a signal transduction
mechanism that senses Mg21 deprivation. The details of this mech-
anism still have to be elucidated. However, it is possible that TRPM7
kinase may be activated during Mg21 deprivation, resulting in phos-
phorylation of various substrates, such as Annexin I and Myosin II,
with a consequent cellular response such as growth arrest.
While our findings suggest that TRPM7 channel activity is not
significantly influenced by its kinase activity, the possibility of kinase
activity being dependent on channel activity cannot be excluded.
Most likely, it is not a simple coincidence that channel domain and
kinase domain have evolved to be encoded in one single molecule.
TRPM7 channel-kinase is localized on the membrane and its kinase
domain is kept anchored in the close proximity to the membrane and
the channel pore. TRPM7 kinase is Mg21-dependent, and is activated
by Mg21 through Mg –ATP41. It is also possible that TRPM7 kinase
can be activated through direct binding of Mg21 to the kinase cata-
lytic domain with subsequent changes in kinase domain conforma-
tion as it was shown for another member of the alpha-kinase family42.
Since TRPM7 channel currents can be facilitated or inhibited by
changes in Mg21 concentrations1, the changes in local concentration
of Mg21 provided by influx through the channel pore may in turn
induce conformational changes in the kinase domain with sub-
sequent opening or closing of the kinase active site therefore making
TRPM7 kinase domain acting as Mg21 concentration sensor. It is
possible that under conditions of Mg21 deprivation TRPM7 channel
is activated and its amplified currents create higher Mg21 concentra-
tions around the channel pore thus activating TRPM7 kinase;
TRPM7 kinase passes the signal downstream by means of phosphor-
ylation of various substrate proteins thus providing a response to
magnesium deprivation. In such a case the absence of TRPM7 kinase
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activity would lead to the absence of normal response to Mg21
deprivation as we observed in our experiments.
In our previous work we showed that deletion of the entire kinase
domain of TRPM7 gene in mice results in early embryonic lethality
while heterozygous mice survived and exhibited altered TRPM7 cur-
rents and hypomagnesaemic phenotype2. However, deletion of
kinase domain most likely resulted in an altered overall structure
of the protein, significantly altering channel pore structure that
results in channel inactivation. Thus, deletion of full kinase domain
can have an effect similar to a deletion of the entire TRPM7 gene.
Indeed, our results with both types of knockout mice (knockout of
the entire gene and deletion of the kinase domain) reveal similar
effects on TRPM7 currents and similar early embryonic lethality
(Ryazanova L.V; manuscript in preparation).
Mg21 plays a critical physiological and pathological role in the
organism. Mg21 deprivation can be regarded as a particular type of
stress: a reduction in serum Mg21 levels leads to a number of poten-
tially fatal health problems, including defects in cardiovascular sys-
tem, motor function, and behavior (reviewed in refs. 35, 43). It has
been demonstrated that Mg21 deprivation results in elevation of
reactive oxygen species and subsequent oxidative stress34,36,44–48.
Since we demonstrated that kinase-dead MEFs are resistant to
Mg21 deprivation and oxidative stress, it is tempting to suggest that
during Mg21 deprivation TRPM7 kinase senses oxidative stress and
participates in the ensuing cellular response. It is possible that the
TRPM7 kinase can act as Mg21 sensor and as such can provide a
response of the cell and the organism to a stressful Mg21 deprivation.
It is likely that TRPM7 kinase role in Mg21 deprivation and oxidative
stress response is a part of a global TRPM7 role in various types of
stress responses of the cell and the organism.
Recent studies revealed the role of TRPM7 in various pathophy-
siological processes including cardiovascular diseases, hypertension,
global ischemia and neuronal cell death (reviewed in ref. 4). In par-
ticular it was shown that oxygen-glucose deprivation-induced neur-
onal death requires TRPM7; it was furthermore suggested that
activation of TRPM7 by reactive oxygen species could cause this
effect49. In the mouse model of global ischemia, suppression of
TRPM7 by small interfering RNA protected neurons in the hip-
pocampus from cell death50. In these studies the involvement of
TRPM7 kinase in cell death was not investigated. Our results suggest
that TRPM7 kinase may be involved in cell death caused by oxidative
stress and therefore could contribute to the effects observed in these
studies. Further research in this direction can investigate the exciting
potential of developing TRPM7 kinase inhibitors as drugs that pro-
tect cells and tissues from oxidative stress during various patho-
logical conditions, for example during ischemia.
To our knowledge this work presents the first report of the physio-
logical function of the TRPM7 kinase activity and demonstrates its
essential role in cellular and systemic response to Mg21 deprivation.
Methods
Animal studies. All animal procedures were carried out in accordance with the
approved guidelines. The procedures were approved by Rutgers Robert Wood
Johnson Medical School Animal Care and Use Committee (Protocol # I12-043-7).
Construction of TRPM7K1646R/K1646R kinase-dead mice. The targeting strategy is
schematically outlined in Figure 1 and is described in detail below. The targeting
vector was constructed by using long homology arm (LA) that extended from 5.31 kb
59 to exon 34 and the LoxP/FRT flanked Neo- cassette. It was inserted in 1.06 kb 39
end and A (4937) R G point mutation was engineered into exon 34. The short
homology arm (SA) extended 2.17 kb 39 to the LoxP flanked Neo-cassette.
Targeted iTl IC1(C57BL/6) embryonic stem cells were microinjected into Balb/c
blastocysts. Resulting chimeras with a high percentage of a black coat color were
mated to wild-type C57BL/6 mice to generate F1 heterozygous offspring. Mouse tail
DNA was analyzed using the following primer set and PCR conditions to determine
the presence of the Neo-cassette:
A2: 59- GTCAAGGAACTACCTGGGAGAGG
F3: 59- GCATAAGCTTGGATCCGTTCTTCGGA
F3 anneals inside the Neo cassette and A2 anneals 39 to the short homology arm,
outside the region used to create the targeting construct. A2/F3 amplifies a fragment
of 2.6 Kb in length. PCR conditions were:
Hot Start 99C for 5 minutes
77C unlimited
1 cycle
Cycling Steps 94C for 20 seconds
62C for 60 seconds
72C for 2 minutes 30 seconds
32 cycles
Cooling Step 4C unlimited
Tail DNA samples from correctly targeted F1 mice were amplified by primer pair






Hot Start 99C for 5 minutes
1 cycle
Cycling Steps 94C for 20 seconds
60C for 30 seconds
72C for 2 minutes
32 cycles
72C for 7 minutes
Cooling Step 4C unlimited
SQ1/UNI amplifies a fragment of 1.75 Kb in length.
The PCR products from the SQ1/UNI reaction were sequenced with SQ2.
T R C point mutation was confirmed to be present in exon 34.
F1 heterozygous mice with K1646R point mutation and Neo-cassette included
were crossed with FLP transgenic mice obtained from Jackson Lab (stock#005703) to
delete the Neo-cassette and produce TRPM7K1646R/1 heterozygous (F2) mice with
point mutation introduced and Neo-cassette deleted.










For the wild-type allele the size of PCR product was about 440 bp. If Neo-cassette
deletion occurred and point mutation was present in the allele, the size of the PCR
product was about 640 bp.
TRPM7K1646R/1 F2 mice with introduced point mutation and deleted Neo- cassette
were crossed with C57BL/6 mice to produce F3 generation of mice with removed
FLP-transgene.









PCR product size was 725 bp when FLP-transgene was present.
TRPM7K1646R/1 F3 mice with introduced point mutation and absent both Neo-
cassette and FLP-transgene were intercrossed to generate homozygous mice carrying
the desired point mutation. Primer sets and PCR condition were the same as
described above.
For PCR reactions Platinum Tag DNA polymerase and DNTP mix from
Invitrogen were used.
All PCR products were separated on 1% agarose gels and stained with ethidium
bromide.
The PCR product for confirming the point mutation (Figure 1C, lane 1) was cut
from the gel, extracted using Qiagen Gel Extraction kit and submitted for sequencing.
Mouse diets and treatment. Mice were kept on 12/12-h light/dark cycle and allowed
ad libitum access to food and water. The following diets were used for the
experiments:
Magnesium deficient diet - 0.0015–0.003% of Mg, Teklad TD.93106,
Control (regular) diet - 0.2% of Mg, Teklad TD.07156.
Magnesium supplemented diet - 0.3% Mg, Teklad TD.120574.
Isolation and culture of primary mouse embryonic fibroblasts. TRPM7 kinase-
dead MEF cells were obtained from E13.5dpc embryos as previously described2. All
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necessary reagents for preparation of MEF cell culture and performing the
experiments were obtained from Invitrogen. Knockout DMEM without magnesium
was custom made by Invitrogen. The absence of Mg21 in the media was confirmed by
Atomic Absorption Spectroscopy analysis. To prepare Mg21-deficient DMEM
dialyzed Knockout Serum Replacement was used. Knockout Serum Replacement was
dialyzed using Slide-A-Lyzer Dialysis Cassette G2 (3,500 MWCO) from Thermo
scientific. Knockout serum replacement was chosen to avoid variations in the quality
of different batches of regular FBS. Residual magnesium level was determined by
Atomic Absorption Spectroscopy analysis and was in 10–15 mM range which
represented Mg21 that could not be completely removed because it was tightly bound
to a serum proteins).
Delayed-hypersensitivity response measurements. Oxazolone was used as a
contact-sensitizing agent. Oxazolone (0.5%) dissolved in acetone was applied on the
shaved mouse abdomen immediately before placing mice on the experimental diets
with various Mg21 content. Control animals were exposed to vehicle alone. Six days
after sensitization, mice were challenged by epicutaneous application of 1% oxazolone
in acetone on their ears. The swelling response was measured 24 h after challenge
using an engineer’s micrometer. Calculations of the swelling response were carried
out by comparing to the respective control groups with no exposure to oxazolone.
Determination of total magnesium in the blood serum and bones. Blood samples
were obtained from the hearts of 6-month old males. Blood serum was isolated by
centrifugation at 1.2 g, 15 min at RT at stored at 280uC. Right tibias were dissected
and cleaned from the muscle tissues and storied at 220uC. Total magnesium levels
were determined using inductively coupled plasma-sector field mass spectrometry
(ALS laboratories, Sweden) as described previously51.
Electrophysiology. Patch clamp experiments were performed in the whole-cell
configuration. Currents were elicited by a ramp protocol from 2100 mV to
1100 mV over 50 ms acquired at 0.5 Hz and a holding potential of 0 mV. Inward
current amplitudes were extracted at 280 mV, outward currents at 180 mV and
plotted versus time. Data were normalized to cell size as pA/pF. Capacitance was
measured using the automated capacitance cancellation function of the EPC-9
(HEKA, Lambrecht, Germany). Average cell capacitance for wild type (WT) MEF
cells assessed at 0 mM Mg21 was 26.4 pF (n 5 5). Average cell capacitance for
K1646R mutant MEF under the same conditions as WT was 23.5 pF (n 5 5). Values
over time were normalized to the cell size measured immediately after whole-cell
break-in. Standard extracellular solution contained (in mM): 140 NaCl, 1.5 CaCl2, 2.8
KCl, 10 HEPES-NaOH, 0.5 Na-EDTA, 11 Glucose (pH 7.2, 300 mOsm). Divalent-
free (DVF) extracellular solution contained (in mM): 140 NaCl, 2.8 KCl, 0 MgCl2, 10
HEPES-NaOH, 1 Na-EDTA, 11 Glucose (pH 7.2, 300 mOsm). Intracellular solution
contained (in mM): 120 Cs-glutamate, 8 NaCl, 10 HEPES-CsOH, 10 Cs-BAPTA and
appropriate amount of MgCl2 was added, as calculated with WebMaxC (Chris Patton,
Stanford) (pH 7.2, 300 mOsm). The intracellular solution for the divalent free (DVF)
extracellular solution experiment contained (in mM): 120 Cs-glutamate, 8 NaCl, 10
HEPES-CsOH, 10 Cs-BAPTA, 1 Na-EDTA (pH 7.2, 300 mOsm). A dose response
curve fit was performed on wild type and K1646R mutant TRPM7 currents extracted
from cells perfused with increasing Mg21 concentrations using the following fit
function: I 5 (Imax *(1/(1 1 (IC50/x)̂ n))); where I is current, Imax is the maximal
current amplitude, IC50 is half maximal inhibitory concentration, and n is the Hill
coefficient. Development of outward currents was quantitated for maximal current
size, time to half-maximal current and rate of current development using a sigmoidal
curve fit function with I 5 IBase 1 (Imax/(1 1 exp((t1/2 2 x)/t))); where I is current,
IBase is the baseline current, Imax is the maximal current amplitude, exp is exponent,
t1/2 is the time to half-maximal current and t is the rate of current development.
Statistical analysis was performed using Student’s t-test.
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